NasdaqGM - Nasdaq Real Time Price USD
Aerovate Therapeutics, Inc. (AVTE)
At close: October 18 at 4:00 PM EDT
After hours: October 18 at 5:04 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
94,217.0000
81,409.0000
53,237.0000
23,022.0000
8,889.0000
--
Operating Income
-94,217.0000
-81,409.0000
-53,237.0000
-23,022.0000
-8,889.0000
--
Net Non Operating Interest Income Expense
6,344.0000
5,945.0000
1,830.0000
65.0000
-75.0000
--
Other Income Expense
-8.0000
-1.0000
-79.0000
-3.0000
-647.0000
--
Pretax Income
-87,881.0000
-75,465.0000
-51,486.0000
-22,960.0000
-9,611.0000
--
Tax Provision
--
56.0000
25.0000
3.0000
--
--
Net Income Common Stockholders
-87,937.0000
-75,521.0000
-51,511.0000
-22,985.0000
-9,764.0000
--
Diluted NI Available to Com Stockholders
-87,937.0000
-75,521.0000
-51,511.0000
-22,985.0000
-9,764.0000
--
Basic EPS
-3.13
-2.87
-2.10
-1.87
-40.17
--
Diluted EPS
-3.13
-2.87
-2.10
-1.87
-40.17
--
Basic Average Shares
28,128.4670
26,331.6300
24,472.1040
12,293.6290
243.0760
--
Diluted Average Shares
28,128.4670
26,331.6300
24,472.1040
12,293.6290
243.0760
--
Total Operating Income as Reported
-94,217.0000
-81,409.0000
-53,237.0000
-23,022.0000
-8,889.0000
--
Total Expenses
94,217.0000
81,409.0000
53,237.0000
23,022.0000
8,889.0000
--
Net Income from Continuing & Discontinued Operation
-87,937.0000
-75,521.0000
-51,511.0000
-22,963.0000
-9,611.0000
--
Normalized Income
-87,937.0000
-75,521.0000
-51,511.0000
-22,963.0000
-9,611.0000
--
Interest Income
6,344.0000
5,945.0000
1,830.0000
65.0000
--
--
Interest Expense
--
--
--
--
75.0000
--
Net Interest Income
6,344.0000
5,945.0000
1,830.0000
65.0000
-75.0000
--
EBIT
-94,217.0000
-81,409.0000
-53,237.0000
-23,022.0000
-8,889.0000
--
EBITDA
-94,108.0000
-81,313.0000
-53,169.0000
-23,007.0000
-8,888.0000
--
Reconciled Depreciation
109.0000
96.0000
68.0000
15.0000
1.0000
--
Net Income from Continuing Operation Net Minority Interest
-87,937.0000
-75,521.0000
-51,511.0000
-22,963.0000
-9,611.0000
--
Normalized EBITDA
-94,108.0000
-81,313.0000
-53,169.0000
-23,007.0000
-8,888.0000
--
Tax Rate for Calcs
--
0.0002
0.0002
0.0003
--
--
12/31/2019 - 6/30/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IKNA Ikena Oncology, Inc.
1.7100
0.00%
SPRB Spruce Biosciences, Inc.
0.5190
+1.76%
ACRV Acrivon Therapeutics, Inc.
8.25
+4.83%
COGT Cogent Biosciences, Inc.
11.90
+2.23%
CGEM Cullinan Therapeutics, Inc.
16.77
-3.45%
BOLD Boundless Bio, Inc.
3.0500
+0.66%
SNSE Sensei Biotherapeutics, Inc.
0.4131
-5.25%
ACET Adicet Bio, Inc.
1.4500
-2.03%
TYRA Tyra Biosciences, Inc.
27.33
+5.20%
ARTV Artiva Biotherapeutics, Inc.
12.17
-4.77%